Health
CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients – News-Medical.Net
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug…
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.
Harnessing CN Bio’s Organ-on-a-Chip technology, the aim of the research is to develop a model capable of recapitulating the fibrosis and tissue remodeling seen in chronic interstitial lung disease,…
-
Noosa News23 hours agoTen people narrowly escape devastating Inala fire in share house without smoke alarms
-
Noosa News20 hours agoFila Casablanca – Concrete Playground
-
Noosa News14 hours agoBrisbane on top as American, Asian tourists flock to city
-
General19 hours agoDebt forecast has alarm bells ringing for Olympic hosts